What Changed at IQVIA

IQVIA launched IQVIA Life Science Models, a suite of purpose built AI models on NVIDIA Nemotron and AWS infrastructure. The models link molecular and treatment information with patient journeys to support study simulation, protocol optimization, digital twins and synthetic control arms.

Our read

Trial sponsors can test study assumptions before enrolling patients. Synthetic controls and digital twins still face regulator scrutiny, so the near term value is in protocol design rather than replacing trial arms.

IQVIA launched Predictive Clinical Development, a suite covering site selection and study design, an automated start up path it calls Push Button Start-Up, and real time data cleaning aimed at shortening the gap to database lock.

Our read

Each of the three targets a different well known delay, and the one worth interrogating is real time data cleaning, because database lock timelines are usually held up by query resolution rather than by query generation. Sponsors evaluating this should ask which of the three has a measured effect on an actual study rather than a modeled one.